文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

高收入国家HIV感染者侵袭性肺炎球菌病与社区获得性肺炎的发病率和危险因素

Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究在荷兰一家HIV转诊中心2008–2017年的PLWH队列中计算IPD和CAP发病率并按CD4计数和cART状态分层,同时开展病例对照研究识别接受cART者CAP的危险因素。结果显示IPD和CAP发病率分别为111和1529/10万随访年,CD4>500 cells/μL者CAP发病率仍高于一般人群(946 vs 188/10万随访年),所有IPD分离株均为疫苗血清型。

要点

  • PLWH中IPD和CAP发病率分别为111和1529/10万随访年。
  • CD4>500 cells/μL者CAP发病率仍高于一般人群(946 vs 188/10万随访年)。
  • 所有IPD分离株均为疫苗血清型,支持按国际建议接种肺炎球菌疫苗。

核心结论

  • PLWH中IPD和CAP发病率仍高于一般人群,即使病毒抑制且CD4计数高。
  • 所有血清分型的IPD分离株均被肺炎球菌疫苗覆盖,为反对当前低接种依从性提供论据。

研究设计与样本

  • 荷兰HIV转诊中心PLWH队列,识别2008–2017年CAP和IPD病例。
  • 按CD4计数和cART状态分层计算发病率,并开展病例对照研究识别接受cART者CAP危险因素。

主要发现

  • IPD和CAP发病率分别为111和1529/10万随访年。
  • CD4<500 cells/μL者IPD的IRR为6.1(95%CI 2.2-17),CAP的IRR为2.4(95%CI 1.9-3.0)。
  • CD4>500 cells/μL者CAP发病率为946/10万随访年,一般人群为188/10万随访年。
  • CAP危险因素包括年龄较大、CD4<500 cells/μL、吸烟、药物使用和COPD。

临床怎么用

  • 应重视PLWH中肺炎球菌疫苗接种,即使CD4计数高且病毒抑制。
  • 对CD4<500 cells/μL、吸烟、药物使用或COPD的PLWH应加强CAP风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although people living with human immunodeficiency virus (PLWH) are at increased risk of invasive pneumococcal disease (IPD) and community-acquired pneumonia (CAP), it is unclear whether this remains the case in the setting of early initiation of combination antiretroviral therapy (cART), at high CD4 cell counts. This is important, as pneumococcal vaccination coverage in PLWH is low in Europe and the United States, despite longstanding international recommendations. METHODS: We identified all CAP and IPD cases between 2008 and 2017 in a cohort of PLWH in a Dutch HIV referral center. We calculated incidence rates stratified by CD4 count and cART status and conducted a case-control study to identify risk factors for CAP in PLWH receiving cART. RESULTS: Incidence rates of IPD and CAP in PLWH were 111 and 1529 per 100 000 patient-years of follow-up (PYFU). Although IPD and CAP occurred more frequently in patients with CD4 counts <500 cells/μL (incidence rate ratio [IRR], 6.1 [95% confidence interval, 2.2-17] and IRR, 2.4 [95% confidence interval, 1.9-3.0]), the incidence rate in patients with CD4 counts >500 cells/μL remained higher compared with the general population (946 vs 188 per 100 000 PYFU). All IPD isolates were vaccine serotypes. Risk factors for CAP were older age, CD4 counts <500 cells/μL, smoking, drug use, and chronic obstructive pulmonary disease. CONCLUSIONS: The incidence of IPD and CAP among PLWH remains higher compared with the general population, even in those who are virally suppressed and have high CD4 counts. With all serotyped IPD isolates covered by pneumococcal vaccines, our study provides additional argumentation against the poor current adherence to international recommendations to vaccinate PLWH.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Garcia Garrido HM, Mak AMR, Wit FWNM, et al. Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting. Clin Infect Dis. 2020. PMID: 31634398. doi:10.1093/cid/ciz728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。